超越乳腺密度:多模态影像中的乳腺癌风险指标
乳腺密度是乳腺癌独立风险因素,数字乳腺摄影和断层合成中按ACR BI-RADS第5版四分类视觉评估。流行病学风险模型(如Tyrer-Cuzick第8版)纳入乳腺密度后建模性能更优。除密度外,乳腺实质纹理复杂性是另一乳腺摄影风险指标,影像组学和深度学习可定量评估纹理并纳入风险模型。乳腺超声和MRI提供独立且互补的风险指标:超声可区分纤维腺体组织的基质和腺体成分,腺体成分较高与风险升高相关;MRI中背景实质强化较高也是风险影像标志。多模态影像标志是超越乳腺密度优化乳腺癌风险预测的有力工具。
要点
- 乳腺密度按ACR BI-RADS第5版四分类视觉评估,是乳腺癌独立风险因素。
- 乳腺摄影纹理复杂性可经影像组学/深度学习定量并纳入风险模型。
- 超声腺体成分较高和MRI背景实质强化较高均与乳腺癌风险升高相关。
关键影像表现/征象
- 数字乳腺摄影和断层合成中,乳腺密度按ACR BI-RADS第5版四分类视觉评估。
- 乳腺摄影上可观察到乳腺实质纹理复杂性,作为独立于密度的风险指标。
- 乳腺超声可分别显示纤维腺体组织的基质和腺体成分,腺体成分较高与风险升高相关。
- MRI上纤维腺体组织背景实质强化较高是风险评定的影像标志。
诊断标准与关键数值
- 乳腺密度评估采用ACR BI-RADS第5版四分类视觉量表(数字乳腺摄影和断层合成)。
- Tyrer-Cuzick模型(第8版)纳入乳腺摄影密度后建模性能更优。
- 乳腺摄影纹理模式可通过影像组学和深度学习定量评估并纳入风险模型。
临床应用与阅片要点
- 阅片报告乳腺密度时按ACR BI-RADS第5版四分类记录,并意识到其独立风险价值。
- 关注乳腺实质纹理复杂性,可辅助风险分层,尤其结合影像组学/深度学习工具。
- 超声评估时注意区分基质与腺体成分,腺体成分较高提示风险升高。
- MRI报告背景实质强化程度,高背景实质强化可作为风险评定标志。
- 多模态影像标志互补,综合应用可优化乳腺癌风险预测。
局限性
- 本文为综述,未报告系统检索策略、纳入文献数量及证据分级。
- 原文未提供各影像标志的具体阈值、敏感度、特异度或AUC等定量数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Breast density is an independent risk factor for breast cancer. In digital mammography and digital breast tomosynthesis, breast density is assessed visually using the four-category scale developed by the American College of Radiology Breast Imaging Reporting and Data System (5th edition as of November 2022). Epidemiologically based risk models, such as the Tyrer-Cuzick model (version 8), demonstrate superior modeling performance when mammographic density is incorporated. Beyond just density, a separate mammographic measure of breast cancer risk is parenchymal textural complexity. With advancements in radiomics and deep learning, mammographic textural patterns can be assessed quantitatively and incorporated into risk models. Other supplemental screening modalities, such as breast US and MRI, offer independent risk measures complementary to those derived from mammography. Breast US allows the two components of fibroglandular tissue (stromal and glandular) to be visualized separately in a manner that is not possible with mammography. A higher glandular component at screening breast US is associated with higher risk. With MRI, a higher background parenchymal enhancement of the fibroglandular tissue has also emerged as an imaging marker for risk assessment. Imaging markers observed at mammography, US, and MRI are powerful tools in refining breast cancer risk prediction, beyond mammographic density alone.
引用
- Acciavatti, Lee, Reig, et al. Beyond Breast Density: Risk Measures for Breast Cancer in Multiple Imaging Modalities. Radiology. 2023. PMID: 36749212. doi:10.1148/radiol.222575
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。